These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7716133)

  • 1. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas.
    Kihara Y; Otsuki M
    Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats.
    Yamazaki Y; Akahane M; Kobayashi M; Takeda H; Ajisawa Y
    Jpn J Pharmacol; 1996 Feb; 70(2):183-90. PubMed ID: 8866756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new benzodiazepine derivative cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats.
    Tachibana I; Otsuki M
    Dig Dis Sci; 1994 Jun; 39(6):1321-8. PubMed ID: 8200267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y; Shiratori K; Iwabe C; Watanabe S; Takeuchi T
    J Gastroenterol; 1996 Apr; 31(2):249-53. PubMed ID: 8680546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini.
    Akiyama T; Otsuki M
    Pancreas; 1994 May; 9(3):324-31. PubMed ID: 8022754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
    Kuno M; Sogabe H; Ito H; Matsuo T; Satoh Y; Motoyama Y; Tanaka H
    Pancreas; 1998 Jul; 17(1):57-64. PubMed ID: 9667521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
    Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K
    Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1994 Mar; 9(2):225-9. PubMed ID: 8190724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
    Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals.
    Yamazaki Y; Shinagawa K; Takeda H; Kobayashi M; Akahane M; Ajisawa Y
    Jpn J Pharmacol; 1995 Dec; 69(4):367-73. PubMed ID: 8786640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
    Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-364,718 on pancreatic exocrine and endocrine secretion in the rat.
    Nakamura T; Fujii M; Okabayashi Y; Tani S; Fujisawa T; Koide M; Otsuki M
    Pancreas; 1990 Mar; 5(2):216-21. PubMed ID: 1690422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.
    Ito H; Sogabe H; Nakarai T; Sato Y; Tomoi M; Kadowaki M; Matsuo M; Tokoro K; Yoshida K
    J Pharmacol Exp Ther; 1994 Feb; 268(2):571-5. PubMed ID: 7509389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats.
    Okumura Y; Inoue H; Fujiyama Y; Bamba T
    J Gastroenterol; 1995 Aug; 30(4):493-9. PubMed ID: 7550860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats.
    Ito H; Sogabe H; Kuno M; Satoh Y; Ogawa T; Konishi K; Yoshida K
    Pancreas; 1998 Oct; 17(3):295-300. PubMed ID: 9788545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions].
    Yamazaki Y; Akahane M; Kobayashi M; Shinagawa K; Sugiura M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):33-44. PubMed ID: 8720296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
    Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
    Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
    Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
    Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.